Man Group
ADPT icon

Man Group’s Adaptive Biotechnologies ADPT Stock Holding History

Man Group’s Portfolio ADPT Stock Details ADPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.97M Sell
91,921
-154,023
-63% -$2.36M ﹤0.01% 1577
2026
Q1 		$3.41M Buy
245,944
+34,654
+16% +$552K 0.01% 1336
2025
Q4 		$3.43M Buy
211,290
+120,129
+132% +$1.96M 0.01% 1238
2025
Q3 		$1.36M Sell
91,161
-3,457
-4% -$42.1K ﹤0.01% 1560
2025
Q2 		$1.1M Sell
94,618
-43,984
-32% -$400K ﹤0.01% 1606
2025
Q1 		$1.03M Sell
138,602
-150,087
-52% -$1.15M ﹤0.01% 1574
2024
Q4 		$1.73M Buy
288,689
+128,317
+80% +$707K ﹤0.01% 1356
2024
Q3 		$821K Sell
160,372
-24,079
-13% -$105K ﹤0.01% 1544
2024
Q2 		$668K Buy
184,451
+6,444
+4% +$20.5K ﹤0.01% 1602
2024
Q1 		$571K Buy
178,007
+6,938
+4% +$26.8K ﹤0.01% 1738
2023
Q4 		$838K Buy
+171,069
New +$781K ﹤0.01% 1509
2023
Q3 		– Sell
-122,508
Closed -$810K – 1437
2023
Q2 		$822K Buy
+122,508
New +$911K ﹤0.01% 1450
2023
Q1 		– Sell
-93,764
Closed -$827K – 1354
2022
Q4 		$716K Sell
93,764
-59,287
-39% -$461K ﹤0.01% 1417
2022
Q3 		$1.09M Buy
+153,051
New +$1.44M 0.01% 1256
2022
Q2 		– Sell
-89,698
Closed -$789K – 1253
2022
Q1 		$1.25M Buy
89,698
+8,102
+10% +$127K ﹤0.01% 1321
2021
Q4 		$2.29M Sell
81,596
-26,981
-25% -$827K 0.01% 1142
2021
Q3 		$3.69M Sell
108,577
-364
-0.3% -$13.2K 0.01% 967
2021
Q2 		$4.45M Sell
108,941
-35,794
-25% -$1.39M 0.02% 936
2021
Q1 		$5.83M Buy
144,735
+3,029
+2% +$164K 0.03% 619
2020
Q4 		$8.38M Sell
141,706
-3,398
-2% -$175K 0.04% 513
2020
Q3 		$7.06M Sell
145,104
-11,527
-7% -$484K 0.03% 634
2020
Q2 		$7.58M Buy
156,631
+134,288
+601% +$4.9M 0.04% 475
2020
Q1 		$621K Sell
22,343
-408,466
-95% -$11.4M ﹤0.01% 1229
2019
Q4 		$12.9M Buy
430,809
+369,397
+602% +$10.6M 0.04% 553
2019
Q3 		$1.9M Buy
+61,412
New +$2.51M 0.01% 1261

Other funds holding ADPT

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Westfield Capital Management
Westfield Capital Management Boston, Massachusetts $30.6B AUM 61.81% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Man Group's ADPT Position: Q2 2026 in Review

Man Group reduced its Adaptive Biotechnologies (ADPT) stake by 63% in Q2 2026, selling an estimated $2.36M and leaving 91,921 shares worth $1.97M. The position accounts for ﹤0.01% of the portfolio, ranked #1577.

Man Group first reported a position in ADPT in Q3 2019 and has held it in 25 quarters since. The position peaked at $12.9M in Q4 2019. 301 funds tracked by Wall St. Rank hold ADPT as of Q2 2026.

  • Man Group held 91,921 shares of Adaptive Biotechnologies worth $1.97M as of Q2 2026.
  • Man Group sold 154,023 Adaptive Biotechnologies shares in Q2 2026, an estimated $2.36M.
  • Adaptive Biotechnologies made up ﹤0.01% of Man Group's portfolio in Q2 2026, its #1577 holding.
  • Man Group first reported a position in Adaptive Biotechnologies in Q3 2019 and has held it in 25 quarters since.
  • Man Group's Adaptive Biotechnologies position peaked at $12.9M in Q4 2019.
  • 301 funds tracked by Wall St. Rank held Adaptive Biotechnologies as of Q2 2026.

Based on Man Group's 13F filing for Q2 2026, filed 14 Aug 2026.